Physician profile
Aaron H Mendelson
NPI 1235499898
$75,121.20
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2021: $29K · 2022: $21K · 2023: $17K · 2024: $7,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Consulting Fee: $1,900 · Food and Beverage: $1,030 · Travel and Lodging: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,384.00 |
| Consulting Fee | $1,900.00 |
| Food and Beverage | $1,030.22 |
| Travel and Lodging | $850.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $70,237.12 | 2021-2024 | Zeposia |
| Abbvie INC. | $1,800.00 | 2022 | |
| Celgene Corporation | $1,492.00 | 2021-2024 | Zeposia |
| Ardelyx, INC. | $1,000.00 | 2024 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $266.09 | 2023-2024 | Entyvio |
| Pfizer INC. | $124.80 | 2019 | |
| Medtronic, INC. | $105.39 | 2021-2023 | Interstim |
| Shire North American Group INC | $28.49 | 2019 | |
| Lilly USA, LLC | $20.84 | 2024 | Omvoh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.29 | 2024 | Xifaxan |
| Ferring Pharmaceuticals INC. | $14.24 | 2023 | Clenpiq |
| Janssen Biotech, INC. | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Mendelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.